{
    "uniprot_canonical_ac": "A0A0G2JVF5-1",
    "uniprot_id": [
        {
            "id": "A0A0G2JVF5_RAT",
            "url": "https://www.uniprot.org/uniprot/A0A0G2JVF5_RAT",
            "type": "external"
        }
    ],
    "mass": 23501.0,
    "length": 204,
    "protein_name": "High mobility group box 3 like 1",
    "gene_name": "Hmgb3l1; Hmgb3",
    "organism": "Rat",
    "refseq_name": "high mobility group protein B3 isoform 3",
    "refseq_ac": [
        {
            "id": "NP_001385706",
            "url": "https://www.ncbi.nlm.nih.gov/protein/NP_001385706",
            "type": "external"
        }
    ],
    "gene_names_uniprotkb": "Hmgb3l1; Hmgb3; Hmgb3l1; LOC108348204",
    "gene_names_refseq": "Hmgb3; RGD1564407",
    "protein_names_uniprotkb": "High mobility group box 3 like 1",
    "protein_names_refseq": "high mobility group protein B3 isoform 3; high mobility group protein B3",
    "tax_id": 10116,
    "disease": "syndromic microphthalmia 13 (Disease Ontology:DOID:0111811)",
    "pathway": "",
    "pathway_count": 0,
    "publication_count": 2,
    "publication_id_list": "30166860;32587254",
    "function": "HMGB3 is involved in malignant transformation of hepatocytes and could be a useful biomarker for diagnosis and a potential target for therapy of liver cancer., [RefSeq, PubMed]; MiR-200b in heme oxygenase-1-modified bone marrow mesenchymal stem cell-derived exosomes alleviates inflammatory injury of intestinal epithelial cells by targeting high mobility group box 3. Publication Status: Online-Only, [RefSeq, PubMed]",
    "predicted_glycosites": 0,
    "predicted_n_glycosites": 0,
    "predicted_o_glycosites": 0,
    "mined_glycosites": 0,
    "mined_n_glycosites": 0,
    "mined_o_glycosites": 0,
    "reported_n_glycosites": 0,
    "reported_o_glycosites": 0,
    "reported_n_glycosites_with_glycan": 0,
    "reported_o_glycosites_with_glycan": 0,
    "total_reported_n_glycosites": 0,
    "total_reported_o_glycosites": 0,
    "total_n_glycosites": 0,
    "total_o_glycosites": 0,
    "reported_fully_resolved_glycans": 0,
    "reported_phosphosites": 0,
    "reported_mutagensis": 0,
    "reported_glycation": 0,
    "reported_snv": 0,
    "reported_interactions": 0,
    "missing_score": 10000,
    "biomarker_type": "",
    "glycan_count": 0,
    "disease_count": 1,
    "glyco_site_count": 0,
    "binding_glycan_count": 0,
    "secondary_ac_list": "",
    "ec_number_list": [],
    "go_molecular_function": "GO:0003677 DNA binding;GO:0003723 RNA binding",
    "go_cellular_component": "GO:0005634 nucleus;GO:0005694 chromosome",
    "go_biological_process": "GO:0045087 innate immune response;GO:0045638 negative regulation of myeloid cell differentiation;GO:0045578 negative regulation of B cell differentiation",
    "synthesized_glycan_count": 0,
    "record_id": "A0A0G2JVF5-1",
    "record_type": "protein",
    "filter_code": "0000000.0000110.100000.0000000000001000.00000.000"
}